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In this study we tested the antiviral activity of a crude hot glycerine extract of Aloe vera gel which was 
grown in Bushehr (Southwest of Iran) against HSV-2 replication in Vero cell line. The extract showed 
antiviral activity against HSV-2 not only before attachment and entry of virus to the Vero cells but also 
on post attachment stages of virus replication. The IC50 before attachment and entry of virus to the cells 
is 428 µg/ml and the CC50 value which is the cytotoxicity of the extract for Vero cells is 3238 µg/ml, while 
the calculated selectivity index (SI) is 7.56. Also, IC50 of extract on post attachment stages of replication 
is 536 µg/ml and the SI value for inhibition of the post attachment stages of HSV-2 replication is 6.04. 
Therefore, compounds of Aloe vera from Bushehr could be a good candidate as a natural source for 
antiviral drug development against HSV-2.  
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INTRODUCTION 
 
People have been using herbal medicines to cure infect-
ious disease from ancient times. In many studies for find-
ing novel antiviral agents, some plants and algae extracts 
were tested on different viruses including the herpes 
viruses (Yoosook et al., 1999; Lopez et al., 2001; 
Sydiskis et al., 1991). Anthraquinone-containing extracts 
from different plant sources such as Aloe vera have 
shown a wide variety of pharmacological activities, such 
as antimicrobial, anti-inflammatory and antitumor 
activities (Bisset, 1994).  
Aloe has been used medicinally for several thousands 
of years in many cultures; from ancient Egypt, Greece, 
and Rome to China and India. The plant has many com-
mon names and is often referred to as burn plant, first-aid 
plant, or medicine plant. Its name is most likely derived 
from the Arabic word Alloeh, meaning “shining bitter 
substance. 
Herpes simplex virus type 2 (HSV-2) is an enveloped 
virus which causes genital herpes and some other impor-
tant complications such as encephalitis, meningitis, eye 
infections and cold  sore.  This  virus  can  produce  latent 
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infection in the host for life and is reactivated by stimulus 
to cause recurrent infections and lesions (Fields, 2001). 
Considering the complications of this virus, some synthe-
tic antiviral compounds such as acyclovir, penciclovir and 
vidarabine were developed for treatment of active herpe-
tic infections, but they are not effective for the treatment 
of latent infections (Naesens and De Clercq, 2001). On 
the other hand the severe side effects and the develop-
ment of some resistant mutants of this virus especially 
during long term medication with antiviral drugs were 
reported (Malvy et al., 2005; Pottage et al., 1995). Also, 
regarding the increasing prevalence of genital herpes, 
there is an urgent need to develop new anti-HSV-2 drugs. 
Because of the reasons mentioned above, finding new 
natural anti herpetic compound(s) is very interesting 
especially from some medicinal plants such as A. vera. 
One of the anthraquinones is emodin which has been 
reported to have antiviral activities to some kind of 
viruses, such as human cytomegalovirus, herpes simplex 
virus type 1 and poliovirus (Bernard et al., 1992; Cohen 
et al., 1996; Semple et al., 2001). It is obvious that the 
effect of the soil composition, climate and other environ-
mental factors could affect the chemical and biological 
composition of A. vera in different area.  
To the best of our knowledge, no research was done to 
evaluate the antiviral activity of A. vera which were grown  
  
 
 
in the south west of Iran. Here, we have attempted to 
evaluate the anti HSV-2 activity of this plant from 
Bushehr port in the south west of Iran.  
 
 
MATERIALS AND METHODS 
 
Preparation of Aloe vera extract 
 
A. vera was collected from the pilot farm of the Jahad Keshavarzi 
Research Centre Bushehr (South west of Iran). The Aloe leaf was 
cut and the fresh gel within the leaf was extracted. The extracted 
gel corresponding to was dissolved in 10% glycerine solution. The 
mixture was boiled for 20 min in 105 ºC. The hot glycerine extract 
was clarified by filtration using Whatman No.1 filter paper. It was, 
thereafter, sterilized by autoclaving.  
 
 
Cell line and virus 
 
Vero cells (African green monkey kidney cell line) were used for 
HSV-2 replication and propagation. Briefly, the cells were grown in 
50 ml cell culture flasks (NUNC) or 24 wells cell culture microplates 
(NUNC) by using Dulbeccos Minimum Essential Medium (Gibco) 
containing 10% foetal bovine serum (Gibco). Herpes simplex virus 
type 2 was isolated from clinical sample and confirmed by using anti 
HSV-2 type specific flourescent monoclonal antibody (DAKO). The 
virus was propagated in Vero cells and the titre of propagated viral 
stock was determined as TCID50/ml by using Karber method. The 
viral stock after titration was dispensed in some sterile tubes which 
were stored at -70ºC. 
 
 
Cytotoxicity test 
 
The cytotoxicity of alga extract was determined by culturing of Vero 
cells for 72 h in the presence of increasing amounts of extract. 
Then viable cells were determined by the trypan blue exclusion test. 
The results were plotted at dose response curve, and by using 
STATA statistical software the 50% cell growth inhibitory concen-
tration (CC50) was obtained. 
 
 
Antivirial activity assay  
 
In this study we used the cytopathic effect inhibition assay for 
evaluation of antiviral activity of the aloe extract. To begin with, 
Vero cells were grown in 24-well plastic plates (7*103 cells /well). 
Then the plates were incubated at 37ºC in the presence of 5% CO2 
until the cells became confluent. Thereafter, the culture medium 
was removed from each well. 0.1 ml of virus suspension containing 
10000 TCID50 and 0.1 ml of DMEM containing 2% FBS were mixed 
in each well of 24-well plates and appropriate concentrations of the 
extract from minimal to maximal non-cytotoxic concentration were 
added to each well based on serial dilution preparation. 
For the virus control 0.1 ml of virus suspension and 0.1 ml of 
culture medium without extract were used. For the cell control 0.1 
ml of culture medium with maximal non cytotoxic concentration of 
extract were added. Also for evaluation of probable antiviral effect 
of 10% glycerine solution 0.1 ml of virus suspension and 0.1 ml of 
sterile 10% glycerine solution without extract were used. The plates 
were incubated at 37ºC in a humidified CO2 atmosphere (5%, CO2) 
and were investigated everyday for CPE presentation until 5 day 
post infection. For testing the probable post attachment antiviral 
effect of the extract, same protocol which mentioned above was 
done but the adding of the extract was two hours post inoculation of 
cells with virus. The degree of inhibition was expressed  as  percent 
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yield of virus control (% virus control = CPE experimental group/ 
CPE virus control *100). The concentration of extract which reduced 
CPE 50% with respect to virus control was estimated from graphic 
plots defined as 50% inhibited concentration (IC50) expressed in 
microgram per milliliter by using STATA modeling software. The 
selectivity index (SI) was measured from the ratio of CC50/IC50 (Kudi 
and Myrint, 1999; Kujumgier et al., 1999). 
 
 
Statistical analysis 
 
STATA statistical analysis package was used for the dose response 
curve drawing in order to IC50 and CC50 calculation. 
 
 
RESULTS 
 
The cytotoxicity of Aloe vera gel crude extract on Vero 
cells was determined by calculation of CC50 which is 
3238 µg/ml. Meanwhile, the 1000 µg/ml of hot glycerine 
extract of A. vera gel showed the cytotoxicity just for 10% 
of Vero cells, 5500 µg/ml of the extract was cytotoxic for 
100% of treated cells.  
Treatment of the Vero cells with different concentra-
tions of crude extract at the same time of inoculation by 
HSV-2 was done based on the method mentioned in 
materials and methods section. Based on results, we 
understood that 100 µg/ml of the extract did not show  
any antiviral effect while the 700 µg/ml of that extract 
could inhibit the performing of cytopathic effect comple-
tely due to HSV-2 replication in Vero cells. Therefore the 
IC50 of this extract by using STATA modelling software is 
428 µg/ml (Figure 1). From the resulting IC50 and CC50 
from extract, the SI value is 7.56 for A. vera gel hot 
glycerine extract. 
The antiviral activity of the crude extracts was tested on 
post attachment stages of the virus replication cycle. It 
was observed that 100 µg/ml of the extract could not 
prevent the performing of cytopathic effect of HSV-2 in 
cell culture and 850 µg/ml of that extract inhibited the 
HSV-2 related CPE performing in Vero cells completely. 
Therefore the IC50 value for filtered extract is 536 µg/ml, 
while the SI value for the antiviral activity is 6.04 (Figure 
2). 
 
 
DISCUSSION 
 
A. vera is a member of the Liliaceae. Topical aloe has 
been used for wounds such as cuts and burns owing to 
its perceived effectiveness in improving healing (Perfect 
et al., 2005). The aloe plant is the source of two herbal 
preparations; aloe gel and aloe latex. Aloe gel is often 
refers to the clear gel or mucilaginous substance pro-
duced by parenchymal cells located in the central region 
of the leaf. Diluted aloe gel is commonly referred to as “A. 
vera extract”. The gel is composed mainly of water (99%) 
and mono- and polysaccharides (25% of the dry weight of 
the gel). The most prominent monosaccharide in AG is 
mannose-6-phosphate, and the  most  common  polysac- 
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Figure 1. Dose response curve of Aloe vera extract against 
HSV-2 (at the same time of virus inoculation). 
 
 
 
 
 
Figure 2. Dose response curve of Aloe vera extract against 
HSV-2 (after virus attachment). 
 
 
 
charides are called gluco-mannans (Shelton, 1991).  
Also, there are some publications about antiviral pro-
perties of different kinds of plant extracts such as A. vera 
especially investigation about the antiviral activity of its 
anthraquinones (Sydiskis, 1991; Andersen et al., 1991). 
Interest in employing antiviral compounds from natural 
sources like plants or algae has been enhanced by 
researchers and also consumers’ preference for natural 
medicines and concerns about the toxic effects of synthe-
tic antiviral materials. In the present study, we chose 
HSV-2 for our research because of its ability for perform-
ing the different clinical complications and its increasing 
prevalence in communities (Rosen, 2006). This is the first 
study about the anti HSV-2 activity of hot glycerine 
extract of A. vera which were grown in Bushehr (South 
west of Iran). We have prepared hot glycerine extract of 
A. vera, because the glycerine extract is enriched for 
anthraquinones present in plants (Sydiskis, 1991). It is 
obvious that the resulting  IC50 and  CC50  values  are  not 
 
 
 
 
comparable with their counterpart studies in which the 
purified effective components such as emodin or another 
anthraquinones were tested.  
For the sterilization of the extract, autoclaving was 
used, and we found that the autoclaved extract showed 
the acceptable IC50. Based on SI values of this extract, it 
could be a good choice for anti- HSV-2 natural com-
pound, although in most studies the filtering method was 
used for extract sterilization. Therefore the A. vera hot 
glycerine extract could be a good choice for preventing of 
virus adsorption, attachment or entry to the host cell. A 
previous study has established that aloe emodin could 
disrupt the envelope of viruses (Sydiskis, 1991). Results 
of the cytotoxicity test indicate that 5500 µg/ml of the 
extract was cytotoxic for 100% of Vero cells. Meanwhile 
other workers reported that aloe emodin of Aloe 
barbadensis did not show remarkable cytotoxic effect 
(Sydiskis, 1991). This difference could be due to the type 
of extract and/or the species of plant or some unknown 
factors. In other studies, stimulation of immune system 
against some viral complications due to Aloe extract were 
established (Gauntt et al., 2000; Iljazovic, 2006). There-
fore, an in vivo study on the antiviral activity or another 
aspect of medical applications of the A. vera of Bushehr 
is recommended. Also, further investigation on the 
antiviral activity of this plant on naked viruses could be 
interesting. It is obvious that for future works, identi-
fication of the effective compounds of the extract and the 
quantitation of these elements are necessary. 
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